Astaxanthin for Parkinson's Disease
Also known as: AstaREAL, Haematococcus pluvialis extract
Astaxanthin protects dopaminergic neurons from oxidative stress and neuroinflammation through BBB-penetrant antioxidant activity.
Mechanism of Action
Astaxanthin protects substantia nigra neurons from MPTP/rotenone-induced toxicity by maintaining mitochondrial membrane potential, reducing ROS, and suppressing microglial activation. Its lipophilic nature ensures accumulation in neuronal membranes.
General mechanism: Carotenoid antioxidant spanning lipid bilayers. Nrf2 activator, NF-κB/STAT3 inhibitor, mitochondrial membrane protector.
Current Evidence
Preclinical PD models show dose-dependent dopaminergic neuroprotection. Anti-inflammatory effects well-documented. No PD clinical trials.
Clinical Status: Preclinical positive. No PD-specific clinical trials yet.
Safety Profile
Very safe. Naturally occurring. FDA GRAS status. No significant side effects. May cause orange skin tint at very high doses.
Key Research Questions
- Can astaxanthin provide long-term dopaminergic neuroprotection in PD?
- Does astaxanthin accumulate sufficiently in the substantia nigra?